Literature DB >> 11411553

Granulomatous tissue formation of shikon and shikonin by air pouch method.

I Sakaguchi1, M Tsujimura, N Ikeda, M Minamino, Y Kato, K Watabe, I Yano, K Kaneda.   

Abstract

"The extract of shikon" (SK) and shikonin play important roles in the development of granulomatous tissue formation. To reveal the augmenting effect of SK or shikonin on vascular endothelial growth factor (VEGF) production and neovascularization, we investigated murine granulomatous tissue induced by SK and shikonin, comparing them to pouches in which trehalose 6,6'-dimycolate (TDM) was injected. The development of granulomatous tissue formation was evaluated by the wet weight of pouch walls. At day 5 and 7 after SK and shikonin injection, prominent granulomatous tissue formation was detected. Histological observations on the development of granulomatous tissue showed that the pouch was formed in the submuscular connective tissue and necrotic tissue directly facing the cavity and granulomatous tissue developed in the connective tissue. At day 1, VEGF-positive neutrophils accumulated in the pouch wall. Granulomatous tissue formation and neovascularization by injection of SK or shikonin was not more prominent than TDM. However, the present results indicate that SK and shikonin induce neovascularization in granulomatous tissue.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11411553     DOI: 10.1248/bpb.24.650

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  9 in total

1.  Evaluation of the effectiveness of an ointment based on Alkannins/Shikonins on second intention wound healing in the dog.

Authors:  Maria Karayannopoulou; Vassiliki Tsioli; Panayiotis Loukopoulos; Tilemahos L Anagnostou; Nikolaos Giannakas; Ioannis Savvas; Lysimachos G Papazoglou; Eleni Kaldrymidou
Journal:  Can J Vet Res       Date:  2011-01       Impact factor: 1.310

2.  Shikonin enhances efficacy of a gene-based cancer vaccine via induction of RANTES.

Authors:  Hui-Ming Chen; Pi-Hsueh Wang; Kandan Aravindaram; Yun-Hsiang Chen; Hsiu-Hui Yu; Wen-Chin Yang; Ning-Sun Yang
Journal:  J Biomed Sci       Date:  2012-04-12       Impact factor: 8.410

3.  Anti-inflammatory properties of shikonin contribute to improved early-stage diabetic retinopathy.

Authors:  Po-Lin Liao; Cheng-Hui Lin; Ching-Hao Li; Chi-Hao Tsai; Jau-Der Ho; George C Y Chiou; Jaw-Jou Kang; Yu-Wen Cheng
Journal:  Sci Rep       Date:  2017-03-21       Impact factor: 4.379

4.  Integrin CD11b negatively regulates Mincle-induced signaling via the Lyn-SIRPα-SHP1 complex.

Authors:  Quanri Zhang; Wook-Bin Lee; Ji-Seon Kang; Lark Kyun Kim; Young-Joon Kim
Journal:  Exp Mol Med       Date:  2018-02-05       Impact factor: 8.718

5.  Biological Effects of Shikonin in Human Gingival Fibroblasts via ERK 1/2 Signaling Pathway.

Authors:  Kazutaka Imai; Hirohito Kato; Yoichiro Taguchi; Makoto Umeda
Journal:  Molecules       Date:  2019-09-30       Impact factor: 4.411

6.  Developing Phytocompounds from Medicinal Plants as Immunomodulators.

Authors:  Chih-Chun Wen; Hui-Ming Chen; Ning-Sun Yang
Journal:  Adv Bot Res       Date:  2012-06-19       Impact factor: 2.175

7.  The Phytochemical Shikonin Stimulates Epithelial-Mesenchymal Transition (EMT) in Skin Wound Healing.

Authors:  Shu-Yi Yin; An-Ping Peng; Li-Ting Huang; Ya-Ting Wang; Chun-Wen Lan; Ning-Sun Yang
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-03       Impact factor: 2.629

8.  Shikonin Promotes Skin Cell Proliferation and Inhibits Nuclear Factor-κB Translocation via Proteasome Inhibition In Vitro.

Authors:  Yan Yan; Minao Furumura; Takako Gouya; Atsufumi Iwanaga; Kwesi Teye; Sanae Numata; Tadashi Karashima; Xiao-Guang Li; Takashi Hashimoto
Journal:  Chin Med J (Engl)       Date:  2015-08-20       Impact factor: 2.628

Review 9.  Pharmacology, toxicity and pharmacokinetics of acetylshikonin: a review.

Authors:  Zhiqin Zhang; Jie Bai; Yawen Zeng; Mengru Cai; Yu Yao; Huimin Wu; Longtai You; Xiaoxv Dong; Jian Ni
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.